Literature DB >> 16510035

Extrahepatic manifestations of hepatitis C virus.

Richard K Sterling1, S Bralow.   

Abstract

Given the high prevalence of chronic hepatitis C virus (HCV) infection, its clinical sequelae account for a significant proportion of patients presenting to gastroenterologists and hepatologists. Whereas the hepatic manifestations of hepatitis C are well described, including hepatitis, cirrhosis, and the development of hepatocellular carcinoma, the extrahepatic manifestations, though common, are less well appreciated. Although nonspecific, fatigue and arthralgias are very common in those with chronic hepatitis C. Extrahepatic syndromes have been reported in as much as 36% of HCV patients, but the exact prevalence is not known. Patients with these syndromes can be divided into those with a high degree of association and those with a more moderate or mild association with HCV. The most prevalent extrahepatic diseases with the highest degree of association with HCV are the essential mixed cryoglobulins with skin, neurologic, renal, and rheumatologic complications. Non-cryoglobulin diseases with a less definite relationship to HCV include systemic vasculitis, splenic lymphoma, porphyria cutanea tarda, and the sicca syndromes. This article highlights the pathophysiology and clinical manifestations of these disorders.

Entities:  

Mesh:

Year:  2006        PMID: 16510035     DOI: 10.1007/s11894-006-0064-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  33 in total

1.  Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients.

Authors:  H Verbaan; J Carlson; S Eriksson; A Larsson; R Liedholm; R Manthorpe; H Tabery; A Widell; S Lindgren
Journal:  J Intern Med       Date:  1999-02       Impact factor: 8.989

2.  Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma.

Authors:  E Zuckerman; T Zuckerman; A M Levine; D Douer; K Gutekunst; M Mizokami; D G Qian; M Velankar; B N Nathwani; T L Fong
Journal:  Ann Intern Med       Date:  1997-09-15       Impact factor: 25.391

3.  Thrombocytopenia associated with hepatitis C viral infection.

Authors:  T Nagamine; T Ohtuka; K Takehara; T Arai; H Takagi; M Mori
Journal:  J Hepatol       Date:  1996-02       Impact factor: 25.083

Review 4.  Renal manifestations of hepatitis C virus infection.

Authors:  R J Johnson; R Willson; H Yamabe; W Couser; C E Alpers; M H Wener; C Davis; D R Gretch
Journal:  Kidney Int       Date:  1994-11       Impact factor: 10.612

5.  Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.

Authors:  S Caronia; K Taylor; L Pagliaro; C Carr; U Palazzo; J Petrik; S O'Rahilly; S Shore; B D Tom; G J Alexander
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

6.  Oral lichen planus and HCV infection: a clinical evaluation of 263 cases.

Authors:  M D Mignogna; L Lo Muzio; G Favia; R E Mignogna; R Carbone; E Bucci
Journal:  Int J Dermatol       Date:  1998-08       Impact factor: 2.736

7.  Porphyria cutanea tarda and hepatitis C virus: a case-control study and meta-analysis of the literature.

Authors:  T Y Chuang; R Brashear; C Lewis
Journal:  J Am Acad Dermatol       Date:  1999-07       Impact factor: 11.527

Review 8.  Hepatitis C virus-associated extrahepatic manifestations: a review.

Authors:  Damien Sène; Nicolas Limal; Patrice Cacoub
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 9.  Extrahepatic manifestations of hepatitis C infection.

Authors:  Marlyn J Mayo
Journal:  Am J Med Sci       Date:  2003-03       Impact factor: 2.378

10.  Thyroid disorders in chronic hepatitis C.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Alessandro Pampana; Poupak Fallahi; Claudia Nesti; Martina Pasquini; Santino Marchi; Ele Ferrannini
Journal:  Am J Med       Date:  2004-07-01       Impact factor: 4.965

View more
  13 in total

Review 1.  Hepatitis C virus and lymphoma.

Authors:  D S Viswanatha; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

2.  Secondary cutaneous marginal zone B-cell lymphoma presenting as lipoatrophy in a patient with hepatitis C.

Authors:  Kristyn Beck; Joan Paul; Shilpa Sawardekar; Valerie Harvey
Journal:  J Dermatol Case Rep       Date:  2014-06-30

3.  Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward.

Authors:  Ayman El Garf; Bassel El Zorkany; Rasha Gheith; Hala Sheba; Geilan Abdel Moneim; Kamal El Garf
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

4.  Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.

Authors:  Reem Hamdy Abdellatif Mohammed; Hesham Ibrahim ElMakhzangy; Amira Gamal; Fatma Mekky; Mohammed El Kassas; Nabil Mohammed; Mohammed Abdel Hamid; Gamal Esmat
Journal:  Clin Rheumatol       Date:  2010-04-22       Impact factor: 2.980

5.  The prevalence of HCV antibodies in skin disease patients in Saudi Arabia.

Authors:  Mona Halawani; Amal Balbisi; Hend Alotaibi; Fahed Alsaif; Talal M Bakir
Journal:  Saudi Pharm J       Date:  2009-12-24       Impact factor: 4.330

Review 6.  Systemic abnormalities in liver disease.

Authors:  Masami Minemura; Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

7.  SASLT practice guidelines: management of hepatitis C virus infection.

Authors:  Abdullah S Alghamdi; Faisal M Sanai; Mona Ismail; Hamdan Alghamdi; Khalid Alswat; Adel Alqutub; Ibrahim Altraif; Hemant Shah; Faleh Z Alfaleh
Journal:  Saudi J Gastroenterol       Date:  2012-09       Impact factor: 2.485

8.  Role of LncRNA-AF085935, IL-10 and IL-17 in Rheumatoid Arthritis Patients With Chronic Hepatitis C.

Authors:  Dina Sabry; Azza Elamir; Rania Hosny Mahmoud; Ahmed Ali Abdelaziz; Wael Fathy
Journal:  J Clin Med Res       Date:  2017-04-01

9.  Measuring the response of extrahepatic symptoms and quality of life to antiviral treatment in patients with hepatitis C.

Authors:  David Isaacs; Nader Abdelaziz; Majella Keller; Jeremy Tibble; Inam Haq
Journal:  Hepat Res Treat       Date:  2013-10-07

Review 10.  Hepatitis C virus as a systemic disease: reaching beyond the liver.

Authors:  Kirat Gill; Hasmik Ghazinian; Richard Manch; Robert Gish
Journal:  Hepatol Int       Date:  2015-12-10       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.